SOUTH SAN FRANCISCO, Calif., Sept. 12, 2019 /PRNewswire/ -- Satsuma Pharmaceuticals, Inc. ("Satsuma" or the "Company") (Nasdaq: STSA), a clinical-stage biopharmaceutical company developing STS101 (dihydroergotamine (DHE) nasal powder) for the acute treatment of migraine, today announced the pricing of its initial public offering of 5,500,000 shares of common stock a

MEXICO CITY, Sept. 12, 2019 /PRNewswire/ -- Genomma Lab Internacional, S.A.B. de C.V. (BMV: LAB B) ("Genomma Lab" or "the Company"), one of the leading pharmaceutical and personal care product companies in Mexico with an expanding international presence is pleased to announce that it has signed an exclu

EBENSBURG, Pa., Sept. 12, 2019 /PRNewswire/ -- This week, workers and their unions are asking for action in the General Assembly on House Bill 1082 and Senate Bill 464. More than 577,000 Pennsylvania public workers deserve the same health and safety protections on the job as private sector workers but are excluded from the prote

EAST STROUDSBURG, Pa., Sept. 12, 2019 /PRNewswire/ -- Personal tragedy, a love for wigs and a vision to address all of the deficiencies she saw in design and quality led visionary Lili Clarke to re

VAUGHAN, ON, Sept. 12, 2019 /PRNewswire/ – CannTrust Holdings Inc. ("CannTrust" or the "Company", TSX: TRST, NYSE: CTST) today is providing a status update in accordance with its obligations under the alternative information guidelines set out in National Policy 12-203 – Management Cease Trade Orders ("NP 12-203"), which require the Company to provide bi-week

PARSIPPANY, N.J., Sept. 12, 2019 /PRNewswire/ -- Castle Creek Pharmaceutical Holdings, Inc. ("CCP Holdings") today announced it has reached an agreement to acquire Fibrocell Science, Inc. (Nasdaq: FCSC), a cell and gene therapy company focused on transformational autologous cell-based therapies for skin and connective tissue diseases.With the resources of CCP

NEW YORK, Sept. 12, 2019 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of owners of the Class A Common Stock of MINDBODY, Inc. (NASDAQ: MB) who sold shares between November 7, 2018 through February 15, 2019, inclusive (the "C

DALLAS, Sept. 12, 2019 /PRNewswire/ -- Trial lawyers for Dallas-based Fears Nachawati Law Firm are welcoming new developments in historic litigation against Big Pharma companies over damages caused by the reckless marketing and distribution of highly addictive opioid-based painkillers.With a team of nationally respected trial

PHOENIX, Sept. 12, 2019 /PRNewswire/ -- We are proud to announce that Dr. Sanford Moretsky and Dr. Craig Cassidy, of Valley Eye Specialists, were amongst the first select group of eye surgeons nationally to implant the Alcon AcrySof® IQ PanOptix® Trifocal Intraocular Lens, after F

CHICOPEE, Mass., Sept. 12, 2019 /PRNewswire/ -- SaVida Health, a leader in outpatient medication-assisted treatment for opioid and alcohol addiction, is opening a new treatment center in Vergennes, VT on September 16th.  SaVida Health Vergennes is the fourth Verm